A5079479857- Estrogen and related hormone effects
- Lung Cancer Treatments and Mutations
- Multiple Myeloma Research and Treatments
- Colorectal and Anal Carcinomas
- Lymphoma Diagnosis and Treatment
- Nutrition, Genetics, and Disease
- Colorectal Cancer Treatments and Studies
- Chronic Lymphocytic Leukemia Research
Universidade de Marília
2024
Luigi Sacco Hospital
2016
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2013
Despite improvements in standard therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for patients untreated, diffuse large B-cell lymphoma, up to 40% of these relapse. Lenalidomide alone or combination rituximab has been shown be active relapsed/refractory aggressive lymphomas. In this phase I study we determined the maximum tolerated dose lenalidomide plus elderly (median age 68 years) lymphoma. Four doses (5, 10, 15, 20 mg/day on days 1–14) allocated using...
The objective of this study was to carry out an integrative review analyze the incidence and prevalence breast cancer after hormone replacement therapy. This followed several steps, including identifying topic, structuring research question using PICO strategy, defining inclusion criteria, selecting articles, evaluating analyzing selected studies, interpreting results presenting review. use therapy (HRT) is linked a significantly increased risk cancer, especially with combination increases...